Providing Better Patient Care: Series XVII

February 20-22, 2013
Earn up to 15 hours of continuing education credit.

Session 3 – Innovations in Biologic Drug Therapy: Navigating your way through the Mabs.

Date: 2/22/2013
Check-in and Breakfast: 7:00am - 7:30am
Educational Session: 7:30am - 1:00pm

At the conclusion of the program, the participant should be able to:

Describe biologic drug therapy and where it is currently used in the treatment of disease.
Explain the role of biologic drug therapy in the treatment of rheumatoid arthritis (RA) and cancer.
Discuss the appropriate place in treatment, risks and benefits associates with biologic drug therapy in RA and Cancer.
Describe recent innovations of biology drug therapy in non-RA and cancer diseases.
Understand the challenges in the development of biosimilars in biologic drug pharmacotherapy.

Cindy O'Bryant, Pharm.D., BCOP
Associate Professor, Department of Clinical Pharmacy, University of Colorado School of Pharmacy, Aurora, CO.